Can a simple blood test spot hidden cancers? new study aims to find out
NCT ID NCT07390643
First seen Feb 05, 2026 · Last updated Jun 23, 2026 · Updated 17 times
Summary
This study will test the GRAIL Galleri blood test, which looks for signs of many different cancers in a single blood draw. Researchers will enroll 100 adults who have symptoms that might be cancer. The goal is to see how well the test detects cancer and how it compares to standard diagnostic methods. The study is not yet recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GRAIL Galleri MCED blood test
What this could lead to
If successful, this could show that a simple blood test helps doctors find cancers earlier in people with symptoms, potentially improving outcomes.
What could go wrong
This is a small, early-stage study (100 participants) that is not yet recruiting. The test may miss some cancers or give false alarms, leading to unnecessary follow-up tests.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.